Alshaima'a M Qunies

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Pharmaceutical patent analyst

This page only lists publications with an associated author ORCID identifier.

Publications

Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Kyle A Emmitte
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. Pharmaceutical patent analyst 11 (2) (2022)